Patent issues of genomics research
β Scribed by Catherine M. Polizzi; Debra A. Shetka
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 125 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
β¦ Synopsis
The interface between the science of genomics and the law of protecting inventions has been fraught with controversy. This paper starts with a basic primer on US patent law followed by a review of the patent issues related to genomics discoveries, in particular, expressed sequence tags (ESTs). Particular focus is placed on the positions expressed by those within the National Institutes of Health and the US Patent and Trademark Office about policy questions and patentability issues for ESTs. The paper concludes with a report on the status of patent law issues related to genomics and discusses those issues yet to be resolved.
π SIMILAR VOLUMES
Over the past two decades, competition in the pharmaceutical industry has been characterized by three factors: 1. Competitive advantage driven by blockbuster drugs 2. Vertical integration from discovery through sales 3. Peripheral role as suppliers in the health care system In this environment, suc
## Abstract For Abstract see ChemInform Abstract in Full Text.
## Abstract For Abstract see ChemInform Abstract in Full Text.